R1 RCM’s customer map: revenue-driving contracts, concentrated risk, and the Phare OS pivot

R1 RCM provides outsourced, technology-enabled revenue cycle management (RCM) to large health systems and physician groups and monetizes through long-term service contracts, platform licensing and success-based fee arrangements that scale with client volume and collections. The business combines high contract stickiness with concentrated customer exposure, and its growth strategy now emphasizes its Phare Revenue Operating System as a cross-sell lever. For primary research and analytical tools on RCM relationships visit https://nullexposure.com/.

Why customers sign multi-year R1 deals (and the implications for investors)

R1’s go-to-market is built on enterprise conversions: multi-year, often exclusive arrangements that move a client’s revenue cycle operations onto R1’s people, processes and software. That contracting posture yields predictable recurring revenue but amplifies concentration and operational risk when large clients experience migration friction or dispute outcomes. Key operating signals:

• Contracting posture: Large-scale, long-duration deals (examples below include 10-year exclusive agreements) indicate deliberate lock-in but require flawless execution during migrations.
• Revenue concentration: R1 reports a small number of large system customers account for a disproportionate share of revenue, creating idiosyncratic sensitivity to client disputes or contract terminations.
• Criticality: R1’s services are mission-critical to client cash flow and billing; that creates strong switching costs once live, but also high stakes during go-lives.
• Maturity and platform push: The company is transitioning from services-heavy revenue to an operating-system-led model (Phare OS), positioning software monetization and platform diffusion as next-phase growth drivers.

Customer relationships that define revenue and risk

Mednax, Inc.

R1 became Mednax’s primary provider of enterprise revenue cycle management, reflecting the firm’s ability to win specialty-group mandates in neonatology and pediatrics. Source: Hit Consultant (May 2021) — https://hitconsultant.net/2021/05/17/mednax-r1-rcm/.

St. Clair Health

R1 signed a 10‑year end-to-end RCM partnership with St. Clair Health, an example of the long-duration contracts central to R1’s model. Source: GlobeNewswire press release (Aug 2022) — https://www.globenewswire.com/news-release/2022/08/25/2504542/0/en/R1-RCM-Announces-10-Year-End-to-End-Revenue-Cycle-Management-Partnership-with-St-Clair-Health.html.

Intermountain Health / Intermountain Healthcare

Intermountain is both a long-standing large client and an active adopter of R1’s Phare OS; Intermountain specifically credited R1 with revenue cycle support during a broad EMR implementation. Source: GlobeNewswire Phare launch release (Oct 2025) and corporate press (FY2025–FY2026) — https://www.globenewswire.com/news-release/2025/10/22/3171051/0/en/R1-Launches-Phare-Healthcare-s-First-Revenue-Operating-System.html and related items.

Singing River Health System

Singing River has signed to leverage R1’s Phare Operating System and publicly confirmed it is live on Phare OS, illustrating early platform adoption among mission-driven providers. Source: GlobeNewswire Phare expansion and Becker’s Healthcare mentions (Apr 2026) — https://www.globenewswire.com/news-release/2026/04/14/3273925/0/en/UPDATE-R1-Announces-Phare-OS-Expansion-to-Help-Providers-Navigate-Growing-Complexity-and-Margin-Pressure.html.

Ascension

Ascension is one of R1’s largest customers and, together with Intermountain, represented about half of R1’s revenue per a company filing; that underscores material client concentration risk. Source: Healthcare Dive reporting on company filing and takeover context (FY2024) — https://www.healthcaredive.com/news/r1-rcm-new-mountain-capital-takeover-offer/708468/.

Sutter Health

Sutter Health executed a 10‑year exclusive agreement with R1 to manage enterprise revenue cycle services, a marquee win that highlights R1’s strategy of large-system exclusivity. Source: GlobeNewswire 10‑year agreement press release (Jul 2022) — https://www.globenewswire.com/news-release/2022/07/14/2480073/0/en/R1-RCM-Announces-10-Year-End-to-End-Revenue-Cycle-Management-Partnership-with-Sutter-Health-to-Drive-Improved-Financial-Performance.html and local reporting.

LifePoint Health

LifePoint is cited among the distinguished systems that have contracted R1 for enterprise RCM, demonstrating R1’s reach into community and regional hospital systems. Source: GlobeNewswire Sutter announcement (Jul 2022) — https://www.globenewswire.com/news-release/2022/07/14/2480073/0/en/R1-RCM-Announces-10-Year-End-to-End-Revenue-Cycle-Management-Partnership-with-Sutter-Health-to-Drive-Improved-Financial-Performance.html.

Penn State Health

Penn State Health is listed as a customer that chose R1 to manage its revenue cycle, indicating R1’s penetration into large academic systems. Source: GlobeNewswire Sutter announcement (Jul 2022) — https://www.globenewswire.com/news-release/2022/07/14/2480073/0/en/R1-RCM-Announces-10-Year-End-to-End-Revenue-Cycle-Management-Partnership-with-Sutter-Health-to-Drive-Improved-Financial-Performance.html.

Quorum Health

Quorum Health is cited alongside other systems as an R1 customer, reflecting R1’s footprint across different ownership models and hospital portfolios. Source: GlobeNewswire Sutter announcement (Jul 2022) — https://www.globenewswire.com/news-release/2022/07/14/2480073/0/en/R1-RCM-Announces-10-Year-End-to-End-Revenue-Cycle-Management-Partnership-with-Sutter-Health-to-Drive-Improved-Financial-Performance.html.

Rush University System for Health (RUSH)

R1 and Rush launched an Innovation Lab to develop mutually beneficial solutions, indicating co‑innovation and collaborative product development with academic systems. Source: GlobeNewswire RUSH press release (Aug 2020) — https://www.globenewswire.com/news-release/2020/08/03/2072051/0/en/RUSH-and-R1-Launch-Innovation-Lab-to-Drive-Industry-Leading-Quality-and-Patient-Experience.html.

VillageMD

VillageMD is named as an R1 client in the Sutter announcement cohort, signaling R1’s relationships with physician-group and primary-care aligned organizations. Source: GlobeNewswire Sutter announcement (Jul 2022) — https://www.globenewswire.com/news-release/2022/07/14/2480073/0/en/R1-RCM-Announces-10-Year-End-to-End-Revenue-Cycle-Management-Partnership-with-Sutter-Health-to-Drive-Improved-Financial-Performance.html.

Providence

Providence has partnered with R1 for multiple years and is now adopting Phare OS innovations across its revenue cycle operations, showing enterprise clients transitioning from service consumption to platform integration. Source: GlobeNewswire Phare OS expansion (Apr 2026) — https://www.globenewswire.com/news-release/2026/04/14/3273925/0/en/UPDATE-R1-Announces-Phare-OS-Expansion-to-Help-Providers-Navigate-Growing-Complexity-and-Margin-Pressure.html.

NuvemRx

NuvemRx acquired the 340B referral capture business formerly known as par8o from R1, indicating selective divestiture of non-core assets as R1 sharpens platform focus. Source: Healthcare IT Today (Feb 2026) — https://www.healthcareittoday.com/2026/02/17/nuvemrx-acquires-par8o-from-r1-rcm-strengthening-its-specialty-care-coordination-and-340b-referral-capture-capabilities/.

New Mountain Capital

New Mountain Capital submitted an acquisition proposal to R1’s special committee in July 2024, a milestone that has influenced strategic review and takeover dynamics. Source: Accesswire shareholder notice (FY2024) — https://www.accessnewswire.com/newsroom/en/business-and-professional-services/r1-rcm-inc.-shareholders-are-notified-that-an-investigation-has-b-891888.

TowerBrook

TowerBrook made a non-binding proposal linked to a potential rollover option for existing private capital holders, reflecting competing financial sponsor interest in R1. Source: Accesswire takeover reporting (FY2024) — https://www.accessnewswire.com/newsroom/en/business-and-professional-services/r1-rcm-inc.-shareholders-are-notified-that-an-investigation-has-b-891888.

Pediatrix

Pediatrix publicly severed ties with R1 after problems migrating to the software, a high-profile client departure that underscores execution risk during platform conversions. Source: Healthcare Dive (FY2024 reporting) — https://www.healthcaredive.com/news/r1-rcm-new-mountain-capital-takeover-offer/708468/.

Translating client wins and losses into an investment framework

R1’s balance of large, sticky contracts against concentrated revenue exposure is the central investment thesis. The company’s Phare OS rollout converts services into platform economics, which improves margins if scaled widely, but every large-client migration is now both a revenue opportunity and a headline risk. Recent events to weigh:

• Concentration drag: Filings and press indicate Ascension and Intermountain together account for roughly half of revenue, a single-event vulnerability for collections and guidance.
• Execution risk: Pediatrix’s termination demonstrates that go-live failures translate into both revenue loss and reputational impact.
• Platform upside: Multiple clients (Providence, Intermountain, Singing River) are adopting Phare OS, validating R1’s strategic pivot toward software-led revenue.
• M&A and governance: Bid activity from New Mountain Capital and TowerBrook places strategic outcomes—take-private, carve-up, or continued public operation—squarely in play for shareholders.

For a concise, investor-grade dossier on R1’s customer portfolio and contract structure, see our research hub at https://nullexposure.com/.

Bottom line: risk-calibrated exposure with a platform inflection

R1’s revenue cycle franchise offers durable recurring cash flows via multi-year contracts and notable platform cross-sell potential through Phare OS, but investors must price in idiosyncratic client concentration and migration execution risk. Active monitoring of large-client migrations, contract renewals and any resolution of takeover activity will be the primary drivers of upside or downside from here.